|
|
CLINICAL UPDATE |
|
Year : 2021 | Volume
: 8
| Issue : 3 | Page : 161-166 |
|
Respiratory acidosis and alkalosis
Kundan Mittal1, HK Aggarwal2, N Rungta3, Vinayak Patki4
1 Department of Pedaitrics, Pt B D Sharma, PGIMS, Rohtak, Haryana, India 2 Department of Medicine and Nephrology, Pt B D Sharma, PGIMS, Rohtak, Haryana, India 3 Department of Critical Care Medicine, JNU Hospital, Jaipur, Rajasthan, India 4 Department of Pediaitric Critical Care, Advanced Pediatric Critical Care, Wanless Hospital, Miraj, Maharashtra, India
Date of Submission | 25-Feb-2021 |
Date of Decision | 12-Mar-2021 |
Date of Acceptance | 22-Mar-2021 |
Date of Web Publication | 21-May-2021 |
Correspondence Address: Dr. Kundan Mittal Pt B D Sharma, PGIMS, Rohtak, Haryana India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jpcc.jpcc_20_21
Respiratory illnesses and failure are common in pediatric population compared to adults due to anatomical and physiological differences in respiratory system. Respiratory acidosis is commonly seen in intensive care settings and needs immediate attention. Treatment depends on underlying pathology and mechanical ventilation. Respiratory alkalosis is least common only mainly iatrogenic or child is hyperventilating.
Keywords: Respiratory acidosis, respiratory alkalosis, respiratory failure
How to cite this article: Mittal K, Aggarwal H K, Rungta N, Patki V. Respiratory acidosis and alkalosis. J Pediatr Crit Care 2021;8:161-6 |
Respiratory Acidosis | |  |
A 10-year-old female child brought history road-side accident. Child was sitting unstrained in front seat. On arrival child was unconscious, respiratory rate was 8/min, jerky, oxygen saturation in room air 88%, Pulses were weak, extremities cold, 112/min, blood pressure 84/54 mmHg, no evidence of external bleed. Child was immediately intubated and mechanically ventilated. Mode of ventilation was ACMV (volume control), FiO2 100%, rate 16/min, inspiratory time 0.6 seconds, PEEP 5, trigger sensitivity 2 L/min. Her ABG revealed pH 7.30, PaO2 58, PCO2 80, HCO3−28.
Objectives
- Defining the respiratory acidosis
- Etiology of respiratory acidosis
- Clinical features
- Management of acute and chronic respiratory acidosis.
To ensure normal functions of cellular enzymes body pH is regulated very tightly (7.35–7.45). Similarly, cell pH is also regulated between 7.0 and 7.3 depending on cell type. Normal PCO2 of around 40 mmHg is regulated by alveolar ventilation and PCO2 level is further maintained by CO2 production (metabolism of carbohydrates and fats), transport (plasma and red blood cells [RBCs]), excretion (alveolar ventilation), and central nervous system (central and peripheral chemoreceptors, medulla and pons and respiratory muscles). When carbohydrate is metabolized 1 mmol of CO2 is produced by consuming 1 mmol of oxygen (RQ 1) and less CO2 is produced when fats utilize the oxygen (RQ 0.7). The production of CO2 varies in different conditions in different organs of body. As soon as PCO2 rises, the pH falls. This is immediately (within minutes) buffered by nonbicarbonate buffers (hemoglobin, plasma proteins and phosphate) so that HCO3 − is not used. The acute non-bicarbonate buffer response is completed within 10–15 min, and steady-state persists for 1 h and if hypercapnia continues for >12 h, the kidneys generate additional HCO3−. Respiratory acidosis can be classified acute (<12 h) or chronic (>3–5 days) types depending on duration. Acute and chronic hypercapnia are associated with hypoxemia. It should be clear that CO2 per se is not acidic but combines with water inside blood. Carbon dioxide is major stimulus of ventilation and for every 1 mmHg PCO2, the minute ventilation rises 1-4 L. Rise in PCO2 is associated with fall in arterial PaO2 since sum of partial pressure of gases in alveoli must remain equal to atmospheric pressure thus hypoxemia is more prominent than hypercapnia (CO2 diffuses more quickly i.e., 20 times than oxygen and oxygen cannot be taken up by fully saturated hemoglobin in normal segment of lung). Hypoxemia stimulates ventilation when PaO2 is 50-60 mmHg. Falling PCO2 and rising pH also blunt the hypoxemic response. Hypoxemia and normocapnia in child with asthma reflects severe attack. Small rise in CO2 in patient with intrinsic lung disease reflects severe dysfunction. Acute respiratory acidosis is associated with rise in catecholamines, glucocorticoids, aldosterone, renin and antidiuretic hormone (ADH) leading to water and sodium retention. Cardiac manifestations in such patients are due to hypoxia (alveolar hypoventilation) and electrolyte (associated metabolic acidosis) disturbances.
Compensatory response:
Acute (10 min) =1 mEq in bicarbonate for every 10 mmHg in PCO2
OR HCO3−= 0.1 x PCO2
Chronic (3-5 days) =3.5 mEq in bicarbonate for every 10 mmHg in PCO2
OR HCO3−= 0.4 x PCO2
Acute respiratory disorders:
Δ ↓ pH + 0.008 × Δ ↑ PCO2
Chronic respiratory disorders
Δ ↓ pH + 0.003 × Δ ↑ PCO2
Acute respiratory acidosis: D H+/DPCO2 > 0.7
Acute on chronic respiratory acidosis: D H+/DPCO2 0.3–0.7
Chronic respiratory acidosis: D H+/DPCO2 < 0.3
H+ =24 (PCO2/HCO3−)
- If pH is normal then directional PCO2 will classify respiratory disorder
- If pH and bicarbonate and carbon dioxide are in opposite direction, defect is of respiratory origin [Table 1].
- Bicarbonate usually increase up to 45 mEq/L and beyond this suspect mixed disorder.
Hypercapnia may result due to over production, decreased alveolar ventilation, impaired gas exchange, decreased respiratory center response, chest wall and respiratory muscles abnormalities. Thus, any pathology involving central nervous, system, neuromuscular diseases, spinal cord injury, foreign body aspiration, laryngospasm, obstructive sleep apnea, acute respiratory distress syndrome (ARDS), pulmonary edema, severe asthma, metabolic alkalosis, chest wall defects, massive pleural effusion, pneumothorax, airway obstruction, increased work of breathing, and ventilatory/gas exchange defects, drugs like opiates, organophosphate poisonings, sepsis, shock, electrolyte abnormalities, multiorgan failure, tetanus, status epilepticus, extreme obesity, increase glucose load in diet, cardiac arrest, Guillain-Barre' syndrome, poliomyelitis, tetanus, myasthenia crisis, neuromuscular blockers use, diaphragm paralysis, iatrogenic hypoventilation, permissive hypercapnia, and inappropriate ventilatory settings (minute ventilation [RR X TV], tidal volume set or generated [peak inspiratory pressure (PIP) in pressure mode] may be low <6 mL/kg), rate set is low or trigger sensitivity is high, pressure support may be less for supported breaths, flow set may be low or inspiratory time may not be age appropriate] are associated with increased blood carbon dioxide level.
Symptoms and Signs of Hypercapnia | |  |
Symptoms and signs are as a result of sympathetic stimulation, peripheral vasodilatation, cerebral vasodilatation, cerebral depression, and decreased diaphragm contractility and endurance.
- Nausea, vomiting, irritability, confusion, raised intracranial pressure (ICP) (increase blood volume and vascular pressure), cerebral vasodilatation, papilledema
- Increase in heart rate, blood pressure, cardiac output, arrhythmias and coronary vessels dilatation are due to sympathetic over activity
- Initial renal vasodilatation and followed by vasoconstriction if PCO2 >70 mmHg. Renin-angiotensin and ADH secretion may also increase.
- Increase gastric acid production
- Respiratory muscle fatigue due to decrease diaphragmatic contractility and endurance
- Shift of oxygen-dissociation curve to right in acute phase and back towards normal side in chronic phase due to decrease in 2,3-DPG level in RBC's
- Secondary polycythemia in chronic cases
- Hypercapnia is associated with hypoxemia and usually seen early as partial pressure of gases in alveoli must equal to atmospheric pressure. Patient hyperventilate to excrete carbon dioxide but oxygen saturation is 100% so no more oxygen is taken up
- Decreased glucose uptake by peripheral tissues and inhibit anaerobic glycolysis
- In chronic cases respiratory center become less sensitive to PCO2.
Types of Respiratory Failure | |  |
- Type I (hypoxemic respiratory failure): PaO2 is <60 mmHg (<8KPA) and normal or increased CO2, or SPO2 <92%
Possible mechanisms:
- Ventilation/perfusion mismatch
- Shunt
- Alveolar hypoventilation
- Diffusion defect
- Perfusion/diffusion impairment: Hepatic failure, right to left intracardiac shunt
- Decreased inspired O2
- Type II (Hypercapnic Respiratory Failure or Pump or Ventilatory): PCO2 is elevated >50 mmHg with or without hypoxemia
Correlation of symptoms and signs with level of rise in PCO2 above baseline:
- 5 mmHg: Hot hands
- 10 mmHg: Rapid bounding pulse, small pupils
- 15 mmHg: Engorged fundal veins, confusion or drowsiness, muscular twitching
- 30 mmHg: Depressed tendon reflexes, depressed extensor plantar responses, and coma
- 40 mmHg: Papilledema
Possible mechanisms:
- Insidious exposure
- Increased CO2 production
- Impaired respiratory control
- Impaired respiratory efforts
- Increased work of breathing.
- Type III (Per-operative Respiratory Failure): Functional residual capacity falls below closing capacity as a result of atelectasis. Various contributing factors are general anesthesia, pain, supine posture and depressed cough reflex.
- Type IV (Shock with hypoperfusion): Perfusion increased to respiratory muscles and resulting in decreased coronary perfusion.
- Mixed Type: Mix of Type I and Type II
- Acute on chronic respiratory failure
- Chronic respiratory failure: Near normal pH >7.30, HCO3−>32, PCO2 >60
Investigations | |  |
General investigations
- ABG: ABG will reveal raised PCO2, fall in pH and compensatory increase in HCO3−, slight increase in sodium, potassium, phosphate and decrease in chloride level. Also measure calcium and magnesium level (slight increase level may be observed). Normal anion gap is reported in respiratory acidosis
- Urine: pH <5.5
- Chest radiography and electrocardiography
- Complete blood count (CBC), Bronchoscopy, pulmonary function tests
- Alveolar-arterial oxygen difference will help in differentiating between lung parenchymal diseases and extrapulmonary disorders.
Type I: Complete history, physical examination, ABG on room air, A-a gradient, pulse oximetry, chest X-ray, CBC, Electrolytes and blood glucose, HRCT, VQ scan.
Type II: Chest X-ray, pulse oximetry, ABG in room air.
Treatment:
- Objectives are to eliminate CO2, decrease CO2 production, correcting pH tolerating hypercapnia and correct the underlying pathology
- Secure airway: Intubate the child if in coma or altered sensorium, PCO2 >80, pH <7.10, poor respiratory efforts, hemodynamically unstable and ARDS
- Administer oxygen to correct hypoxemia. Avoid excessive oxygen in chronic hypercapnia to prevent CNS depression (maintain PO2 60–70 mmHg and saturation 88%–93%)
- Assisted ventilation: Mechanical ventilation is not required in conscious and hemodynamically stable children. Noninvasive ventilation (BiPAP) may be used in children who are hemodynamically stable, conscious and able to handle secretions. Increase IPAP by 2 (If issue is ventilation) and if oxygenation is concern, increase EPAP by 2 and IPAP also by same value). Usually maintain difference between IPAP and EPAP of five and measure PCO2 after every hour.
Invasive ventilation
Indications:
- Cardio-respiratory arrest, impending respiratory arrest
- Respiratory muscle fatigue
- Severe hypercapnic respiratory failure
- Refractory hypoxemia not responding to non-invasive ventilation
- Severe metabolic acidosis
- Glasgow Coma Scale <8
- Unable to protect airway.
The initial ventilatory settings depend on patient body weight, disease process, patho-physiology and laboratory studies. The initial settings are just guidelines and have to be modified depending on patho-physiological changes and improvement of patient.
Many ventilators ask for patient weight, age, leak and tubal compensation, sigh breath, inspiratory limbs etc., Most of the present-day ventilator will blink light for setting parameters once the mode of ventilation is selected. In pediatric population pressure-controlled ventilation is preferred mode of ventilation. Initially children are put on A/CMV or SIMV mode. In this mode we have to set the Ti time. Flow is automatically adjusted. In some situation we may set PRVC/VTPC mode, a dual control mode, where set tidal volume is delivered by adjusting pressure within limits.
Initial Ventilator Settings: We may have to ventilate four types of lung pathology (normal lung, restrictive, or obstructive diseased pathology, or diffusion defect). Depending on pathology settings are adjusted.
PCV: Assist Control: RR (physiological), PIP 20, PEEP 5, FiO2 100%, Pressure or flow trigger, monitor PIP to adjust TV 6-8 mL/kg/IBW.
VCV: Assist Control: RR, TV 6-8 mL/kg/IBW, PEEP 5, FiO2 100%, decelerating waveform.
SIMV (PCV or VCV): Set SIMV rate and pressure support to get tidal volume of 6-8 mL/kg/IBW. Rest of parameters will remain same depending on mode.
- Adjust FiO2 based on saturation and PaO2
- Adjust PEEP depending on hypoxemia
- Adjust PIP and PS for tidal volume.
- Role of sodium bicarbonate is limited to few cases only. Sodium bicarbonate infusion is harmful in patient with pulmonary edema. It can increase CO2 production and more over it has no effect on central nervous system. Metabolic alkalosis is another issue once PCO2 turns towards normal. Associated metabolic alkalosis may be treated using normal saline therapy and discontinuing diuretics
- Antibiotics, bronchodilators, steroids as per condition
- Avoid high carbohydrate diet in mechanically ventilated child
- Avoid sedatives and neuro-suppressants
- Control excessive CO2 production (control fever, avoid high carbohydrate diet, overfeeding, use of fat reach diet, hypothermia)
- Treatment of chronic respiratory acidosis includes addressing underlying etiology, adequate oxygenation (PaO2 60-70 mmHg and oxygen saturation 88-93%), treatment of infections, bronchodilator therapy, diet modification to reduce CO2 production.
Respiratory Alkalosis | |  |
A 12-year-old male child, a known case of asthma brought with acute exacerbation of asthma for the last 6 h following acute respiratory tract infection. He was already on inhaled bronchodilator and corticosteroids. On examination respiratory rate 38/min with increased work of breathing, oxygen saturation 92% in room air, heart rate 112/min, blood pressure 1110/70. His ABG report is pH 7.5, PCO2 20 mmHg, PaO2 72 mmHg, HCO3 − 18 mEq/L, Serum sodium 134 mEq/L, K + 3.4 mEq/L, Cl 98 mEq/L, CBC (TLC 16400. cmm, P80, L18).
Objectives
- Defining respiratory alkalosis
- Etiology of respiratory alkalosis
- Management of child with respiratory alkalosis
Respiratory alkalosis is characterized by primarily decrease in PCO2 (<35 mmHg in setting of alkalemia) and increase in pH >7.45. Primary hypocapnia reflects hyperventilation and secondary hypocapnia is in response to metabolic acidosis. Compensatory response to respiratory alkalosis is decrease in serum bicarbonate level. Respiratory alkalosis may be as a result of increased alveolar ventilation or decreased CO2 production or combination of both. Respiratory alkalosis can be acute or chronic depending upon the duration.
Compensatory Changes | |  |
Acute (10 min) =2 mEq ↓ in bicarbonate for every 10 mmHg ↓ in PCO2
HCO3−=0.2 x PCO2
Chronic = 5 mEq ↓ in bicarbonate for every 10 mmHg ↓ in pCO2
HCO3−=0.5 x PCO2
Acute respiratory alkalosis: ↑ΔpH = 0.01 x ↓ΔPCO2
↓ΔH− =0.75 x ↓ΔPCO2
H− = (0.75 x PCO2) +10
Chronic respiratory alkalosis: ↑ΔpH = 0.0003 x ↓ΔPCO2
↓ΔH− =0.75 x ↓ΔPCO2
H− = (0.3 x PCO2) +28
Etiology
Respiratory alkalosis is common in anxiety, pain, central hyperventilation, high altitude, fever, encephalopathy, meningitis, cerebral edema, severe anemia, hypotension (tachypnea, hypoxia), tissue hypoxia, congestive cardiac failure, cold shock, pneumonia, acute asthma exacerbation, pulmonary embolism, pulmonary edema, pneumothorax, interstitial lung disease (hypocapnia and hypoxemia), hemodialysis, acidosis, inappropriate ventilatory settings (high rate, tidal volume), salicylate toxicity, xanthine (hyperventilation) toxicity, gram-negative sepsis (fever, hypotension and hypoxemia), hepatic failure (cerebral hypoxia, increased level of ammonia and progesterone), heat stroke, sepsis (fever, hypotension, hypoxemia).
Clinical signs and symptoms are basically seen in acute phase which include various neurological [decrease in cerebral blood flow (PCO2 between 15 and 20 mmHg is associated with 45% decrease in blood flow), seizure, confusion, tingling sensation in limb, decrease in ICP and intraocular pressure, generalized slowing and high voltage EEG, and ionized calcium level], cardiovascular (decrease blood pressure, cardiac output, coronary blood flow, myocardial oxygen supply, cardiac arrhythmias, increased peripheral resistance, decrease tissue perfusion), metabolic effects (increased lactate production, decrease plasma volume, serum sodium, potassium, phosphate, ionized calcium, increased binding of calcium to albumin and chloride level), hypoxemia, shift of ODC to left, increased affinity to oxygen, increased oxygen uptake and decreased oxygen release to tissues, increased 2, 3-DPG level and hemoconcentration due to shift in plasma. In acute phase urinary pH is >7.0 and in chronic respiratory alkalosis it is <6.0. In chronic respiratory alkalosis urinary SID is also increased.
Diagnosis
Detailed history including medications, physical examination, blood gas analysis, CBC, serum electrolytes, chest X-ray, blood culture and other tests performed to know the etiology of respiratory alkalosis. Serum bicarbonate may fall up to 12 mEq/L and always consider associated metabolic acidosis if value falls below 12.[1],[2],[3],[4],[5],[6],[7],[8],[9],[10],[11]
Treatment | |  |
Respiratory alkalosis is not a benign condition and needs correction of primary etiology.
- If the patient is on mechanical ventilator appropriate ventilatory adjustment is made. We may also use sedatives to decrease respiratory derive
- May correct pH using chloride rich fluid tolerating hypocapnia
- Hypoxia is treated by proving supplementary oxygen
- Rebreathe in paper mask or plastic bag in children with anxiety induced hyperventilation
- In suspected salicylate toxicity perform forced diuresis, urine alkalinization and dialysis
- Bronchodilators in child with acute exacerbation of asthma
- Diuretics in case of pulmonary edema
- Beta blockers and antithyroid medications in child with hyperthyroidism.
Pseudo-Respiratory Alkalosis | |  |
Arterial hypocapnia associated with circulatory shock characterized by raised mixed venous carbon dioxide but normal or decreased arterial carbon dioxide due to decreased delivery to lung and increased pulmonary transient time.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient (s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | |  |
1. | Reddi AS. Fluid, Electrolyte and Acid-Base Disorders: Clinical Evaluation and Management. 2 nd ed. USA: Springer; 2018. |
2. | Mount DB, Sayegh MH, Singh AK. Core Concepts in the Disorders of Fluid, Electrolytes and Acid-Base Balance. USA: Springer; 2013. |
3. | Hasan A. Handbook of Blood Gas/Acid-Base Interpretation. 2 nd ed. India: Springer; 2013. |
4. | Garrette B. Fluids and Electrolytes: Essentials for Healthcare Practice. Oxon: Taylor and Francis; 2017. |
5. | Kamel SK, Halperin ML. Fluid, Electrolyte and Acid-Base Physiology. Philadelphia: Elsevier; 2017. |
6. | Volsko TA, Barnhart SL. Foundations in Neonatal and Pediatric Respiratory Care. Burlington: Jones and Bartlett; 2020. |
7. | Kacmarek RM, Stoller JK, Heuer AJ. Eagn's Fundamentals of Respiratory Care. 12 th ed. Missouri: Elsevier; 2021. |
8. | Chang D. Respiratory Care Calculations. 4 th Revised ed. Burlington: Jones and Bartlett; 2020. |
9. | Baker DJ. Artificial Ventilation: A Basic Clinical Guide. Paris: Springer; 2016. |
10. | Pupella RA. Mechanical Ventilation in Patient with Respiratory Failure. Philippines: Springer; 2018. |
11. | Chang DW, White GC, Waugh J, Restrepo RD. Respiratory Critical Care. Burlington: Jones and Bartlett; 2021. |
[Table 1]
|